REINFARKT MIOKARDA-PRIKAZ SLUČAJA

Ključne reči: Akutni infarkt miokarda, reinfarkt, prehospitalni tretman.

Sažetak


Uvod: Prema Četvrtoj univerzalnoj definiciji infarkta miokada (IM), termin ″reinfarkt″ se klinički koristi za IM koji se javlja u roku od 28 dana od incidentnog ili ponovljenog IM. Odlikuje se ponovnim javljanjem anginoznog bola, porastom kardiospecifičnih enzima i promenama u elektrokardiogramu.

Cilj rada: Ukazati na značaj ranog prepoznavanja i postavljanja prehospitalne radne dijagnoze reinfarkta miokarda nastalog ubrzo nakon prvog IM, sa implikacijom na pozitivan ishod pacijenta.

Prikaz bolesnika:  Broj 194 poziva pacijentkinja starosti 64 godine, zbog naglonastalog bola u grudima koji je praćen povraćanjem. Dva dana ranije otpuštena iz bolnice nakon hospitalizacije zbog IM prednjeg zida. Na EKG zapisu uočavaju se promene ST segmenta koje ukazuju na akutni IM anterolateralne lokalizacije. Ordinirana odgovarajuća terapija, i pod monitoringom vitalnih parametara transportovana u dežurnu angio salu na dalju dijagnostiku i lečenje reinfarkta miokarda.

Zaključak: Brza i pravovremena dijagnostika reinfarkta, imaju ključnu ulogu u daljem lečenju pacijenta.

Reference

1. Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399(10332):1347-58. doi:10.1016/S0140-6736(21)02391-6
2. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes [published correction appears in Eur Heart J. 2024;45(13):1145. doi: 10.1093/eurheartj/ehad870.]. Eur Heart J. 2023;44(38):3720-3826. doi:10.1093/eurheartj/ehad191
3. Radovanović N, Radosavljević-Radovanović M, Dobrić M, Antonijević N, Mitrović P. Akutni infarkt miokarda – pravovremenost i povezanost u zbrinjavanju bolesnika. Acta chirurgica Jugoslavica. 2016; 63(2): 9-13. doi:10.2298/ACI1602009R.
4. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards) Cannon CP, Brindis RG, Chaitman BR, et al. J Am Coll Cardiol. 2013;61:992–1025. doi: 10.1016/j.jacc.2012.10.005.
5. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e651. doi: 10.1161/CIR.0000000000000617. PMID: 30580786.
6. De Luca L, Paolucci L, Nusca A, Putini RL, Mangiacapra F, Natale E, et al. Current management and prognosis of patients with recurrent myocardial infarction. Rev Cardiovasc Med. 2021;22(3):731-740. doi: 10.31083/j.rcm2203080. PMID: 34565072.
7. Schmitz T, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Long-Term Predictors of Hospitalized Reinfarction after an Incident Acute Myocardial Infarction. Life (Basel). 2022;12(12):2090. doi: 10.3390/life12122090. PMID: 36556454; PMCID: PMC9784794.
8. Abreu LM. Time is Muscle. Arq Bras Cardiol. 2019;112(4):408-9. doi: 10.5935/abc.20190059. PMID: 30994719; PMCID: PMC6459437.
9. Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, et al. Characteristics and Outcomes of Early Recurrent Myocardial Infarction After Acute Myocardial Infarction. J Am Heart Assoc. 2021;10(16):e019270. doi: 10.1161/JAHA.120.019270. PMID: 34333986.
10. Butler J, Hammonds K, Talha KM, Alhamdow A, Bennett MM, Bomar JVA, et al. Incident heart failure and recurrent coronary events following acute myocardial infarction. Eur Heart J. 2025:ehae885. doi: 10.1093/eurheartj/ehae885. PMID: 39874177.
11. Agencija za lekove i medicinska sredstva Srbije. Uputstvo za lek: Furosemid Sopharma 10 mg/ml. Dostupno na: https://www.alims.gov.rs/doc_file/lekovi/pil/515-01-00728-20-001.pdf. Pristupljeno: 16.03.2024.
Objavljeno
2025/04/28
Rubrika
Prikaz bolesnika